We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Wingstop and M.D.C.
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 27, 2022 – Today, Zacks Investment Ideas feature highlights Wingstop (WING - Free Report) and M.D.C. .
2 Stocks with Compelling Technical Setups and Top Ranks
By combining the Zacks Rank with technical analysis, investors can improve their odds of trading a winning stock. In this article I will discuss two top-ranked stocks that boast impressive earnings estimate revisions, as well as highly asymmetric technical trade setups.
Wingstop and M.D.C. both have multiple bullish catalysts and make for worthwhile consideration as investments.
Wingstop
Wingstop is chicken wing franchise restaurant chain that has been growing at an incredible pace. Sales since its IPO have been growing nearly 20% annually, and the stock has compounded at an annual rate of 32.5% over the last five years.
However, incredible growth rates like that bring with it premium valuations. Wingstop is trading at a one-year forward earnings multiple of 88x, which is well above the industry average of 26.4x, although just below its five-year median of 100x.
Earnings estimates continue to be revised higher nonetheless, and the stock is benefiting from strong momentum pushing it higher. WING currently has a Zacks Rank #1 (Strong Buy), indicating upward trending earnings revisions.
Current quarter earnings estimates have been increased by 11% over the last two months and are projected to climb 11% YoY. FY23 earnings have been revised higher by 11.5% and are expected to grow 15% YoY. Sales are also expected to maintain their impressive growth rate. Current quarter sales are forecast to grow 24% YoY, and FY23 sales are expected to grow 19.5% YoY.
WING stock made an impressive run from $80 in June 2022 all the way to $220 less than a year later in May of this year. The price has now had almost two months to take a rest and reset for another potential move higher. WING stock has been sold now for the last seven consecutive weeks, but has clearly found support at the prior all-time high and now built out a convincing bull flag.
If the price can break out above the $192 level, it should initiate another bull run that makes an attempt at new all-time highs. Alternatively, if the stock can’t hold the level of support at $185, the setup is invalid, and investors can remain cautious.
M.D.C.
MDC is a US based new home builder that acquires and develops land, constructs homes, markets, sells, and manages customer service. Not only is MDC a Zacks Rank #1 (Strong Buy) stock but it also earns an “A” grade across the Zacks Style Scores.
Additionally, it sits in the top 7% of the Industry Rank, and the #1 position in the Sector Rank. MDC also pays a 4.5% dividend yield, which has increased by 19.5% annually over the last five years.
Current quarter earnings have been revised higher by 8%, while FY23 earnings have been upgraded by nearly 40% and FY24 by 36% over the last two months.
MDC has been building out a convincing technical setup over the last two weeks. If MDC stock can breakout above the $45 level, it should continue its strong run higher. However, if the price can’t hold above $43.75, the setup is invalid, and investors can wait for another setup to form.
Bottom Line
Both Wingstop and M.D.C. make for exciting investment opportunities. They have clearly built out strong business models and are gaining from the strong momentum pulling up many segments of the broad market. When trading from chart patterns like these it is critical for investors to respect their trading plan and know exactly how much money they may lose on any given trade. Picking stocks, and marking up charts is important, but risk management is absolutely key for long-term success.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Wingstop and M.D.C.
For Immediate Release
Chicago, IL – June 27, 2022 – Today, Zacks Investment Ideas feature highlights Wingstop (WING - Free Report) and M.D.C. .
2 Stocks with Compelling Technical Setups and Top Ranks
By combining the Zacks Rank with technical analysis, investors can improve their odds of trading a winning stock. In this article I will discuss two top-ranked stocks that boast impressive earnings estimate revisions, as well as highly asymmetric technical trade setups.
Wingstop and M.D.C. both have multiple bullish catalysts and make for worthwhile consideration as investments.
Wingstop
Wingstop is chicken wing franchise restaurant chain that has been growing at an incredible pace. Sales since its IPO have been growing nearly 20% annually, and the stock has compounded at an annual rate of 32.5% over the last five years.
However, incredible growth rates like that bring with it premium valuations. Wingstop is trading at a one-year forward earnings multiple of 88x, which is well above the industry average of 26.4x, although just below its five-year median of 100x.
Earnings estimates continue to be revised higher nonetheless, and the stock is benefiting from strong momentum pushing it higher. WING currently has a Zacks Rank #1 (Strong Buy), indicating upward trending earnings revisions.
Current quarter earnings estimates have been increased by 11% over the last two months and are projected to climb 11% YoY. FY23 earnings have been revised higher by 11.5% and are expected to grow 15% YoY. Sales are also expected to maintain their impressive growth rate. Current quarter sales are forecast to grow 24% YoY, and FY23 sales are expected to grow 19.5% YoY.
WING stock made an impressive run from $80 in June 2022 all the way to $220 less than a year later in May of this year. The price has now had almost two months to take a rest and reset for another potential move higher. WING stock has been sold now for the last seven consecutive weeks, but has clearly found support at the prior all-time high and now built out a convincing bull flag.
If the price can break out above the $192 level, it should initiate another bull run that makes an attempt at new all-time highs. Alternatively, if the stock can’t hold the level of support at $185, the setup is invalid, and investors can remain cautious.
M.D.C.
MDC is a US based new home builder that acquires and develops land, constructs homes, markets, sells, and manages customer service. Not only is MDC a Zacks Rank #1 (Strong Buy) stock but it also earns an “A” grade across the Zacks Style Scores.
Additionally, it sits in the top 7% of the Industry Rank, and the #1 position in the Sector Rank. MDC also pays a 4.5% dividend yield, which has increased by 19.5% annually over the last five years.
Current quarter earnings have been revised higher by 8%, while FY23 earnings have been upgraded by nearly 40% and FY24 by 36% over the last two months.
MDC has been building out a convincing technical setup over the last two weeks. If MDC stock can breakout above the $45 level, it should continue its strong run higher. However, if the price can’t hold above $43.75, the setup is invalid, and investors can wait for another setup to form.
Bottom Line
Both Wingstop and M.D.C. make for exciting investment opportunities. They have clearly built out strong business models and are gaining from the strong momentum pulling up many segments of the broad market. When trading from chart patterns like these it is critical for investors to respect their trading plan and know exactly how much money they may lose on any given trade. Picking stocks, and marking up charts is important, but risk management is absolutely key for long-term success.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.